406 related articles for article (PubMed ID: 25975562)
21. Circulating tumor cells in prostate cancer: beyond enumeration.
Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
[TBL] [Abstract][Full Text] [Related]
23. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.
Bitting RL; Healy P; Halabi S; George DJ; Goodin M; Armstrong AJ
Urol Oncol; 2015 Mar; 33(3):110.e1-9. PubMed ID: 25595577
[TBL] [Abstract][Full Text] [Related]
24. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
25. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
[TBL] [Abstract][Full Text] [Related]
26. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
27. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
28. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
29. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
30. The origin of prostate metastases: emerging insights.
Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
[TBL] [Abstract][Full Text] [Related]
31. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
[TBL] [Abstract][Full Text] [Related]
32. The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
Beltran H; Jendrisak A; Landers M; Mosquera JM; Kossai M; Louw J; Krupa R; Graf RP; Schreiber NA; Nanus DM; Tagawa ST; Marrinucci D; Dittamore R; Scher HI
Clin Cancer Res; 2016 Mar; 22(6):1510-9. PubMed ID: 26671992
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors.
Goodman OB; Fink LM; Symanowski JT; Wong B; Grobaski B; Pomerantz D; Ma Y; Ward DC; Vogelzang NJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1904-13. PubMed ID: 19505924
[TBL] [Abstract][Full Text] [Related]
34. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
[TBL] [Abstract][Full Text] [Related]
35. The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy.
Lowes LE; Lock M; Rodrigues G; D'Souza D; Bauman G; Ahmad B; Venkatesan V; Allan AL; Sexton T
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):358-64. PubMed ID: 26238233
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
37. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
[TBL] [Abstract][Full Text] [Related]
39. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
[TBL] [Abstract][Full Text] [Related]
40. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
